Kim et al. (2017) recently reported a significant relevance between specific polymorphisms in the MFN2 gene and AD, suggesting a relationship between genetic polymorphisms during fusion and AD pathogenesis. The gene discussed is MFN2; the disease is Alzheimer disease.